CASRN: 10102-17-7
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the clinical use of sodium thiosulfate during breastfeeding. However, it is not absorbed orally and the reported side effect after oral use is diarrhea. Withholding breastfeeding for 1 to 2 hours after a dose should allow the drug to be cleared from the maternal bloodstream and breastmilk. Observe the infant for diarrhea.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Thiosulfate Sodium
CAS Registry Number
10102-17-7
Drug Class
Breast Feeding
Lactation
Milk, Human
Antidotes
Chelating Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
Publication Details
Publication History
Last Revision: September 19, 2022.
Copyright
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Publisher
National Institute of Child Health and Human Development, Bethesda (MD)
NLM Citation
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-. Thiosulfate Sodium. [Updated 2022 Sep 19].